AgingResearch.News
Frontiers in Neurology

Considerations for using amyloid-targeting therapies for the treatment of early symptomatic Alzheimer's disease

By Andrew E. Budson, Peter Alexander Ljubenkov, Aaron Ritter, Show 4 more authorsBrandy R. Matthews
ReviewInterventions
Paper

The paper

Andrew E. Budson, Peter Alexander Ljubenkov, Aaron Ritter, Show 4 more authorsBrandy R. Matthews

Boston University; Eli Lilly (United States)

Frontiers in Neurology, 10 Aug 2026

doi.org/10.3389/fneur.2026.1863897PubMed 42643714

Related